MARIZYME, INC. financial data

Location
Jupiter, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 05 Mar 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3% % -46.65%
Quick Ratio 0% % -85.06%
Debt-to-equity -284% % 95%
Return On Assets -89% % 62%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131,793,088 shares 0%
Common Stock, Shares, Outstanding 131,793,088 shares 182%
Common Stock, Value, Issued $131,792 USD 182%
Weighted Average Number of Shares Outstanding, Basic 131,793,088 shares 188%
Weighted Average Number of Shares Outstanding, Diluted 131,793,088 shares 188%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $549,691 USD -74.53%
Cost of Revenue $158,480 USD -75.44%
Research and Development Expense $1,365,454 USD -44.73%
Operating Income (Loss) $-26,608,923 USD 31%
Nonoperating Income (Expense) $7,462,721 USD 97%
Net Income (Loss) Attributable to Parent $-19,146,202 USD 78%
Earnings Per Share, Basic 0 USD/shares 92%
Earnings Per Share, Diluted 0 USD/shares 98%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $2,000 USD -95.37%
Inventory, Net $26,869 USD -72.86%
Assets, Current $854,594 USD -34.98%
Property, Plant and Equipment, Net $12,500 USD 0%
Operating Lease, Right-of-Use Asset $797,405 USD -33.45%
Goodwill $5,416,000 USD -24.68%
Assets $21,256,297 USD -42.43%
Liabilities, Current $29,977,203 USD -46.58%
Operating Lease, Liability, Noncurrent $355,184 USD -53.68%
Liabilities $36,795,387 USD -44.52%
Retained Earnings (Accumulated Deficit) $-170,320,946 USD -12.66%
Stockholders' Equity Attributable to Parent $-15,539,090 USD 47%
Liabilities and Equity $21,256,297 USD -42.43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-808,951 USD 28%
Net Cash Provided by (Used in) Financing Activities $666,632 USD -29.01%
Common Stock, Shares Authorized 2,000,000,000 shares 0%
Common Stock, Shares, Issued 131,793,088 shares 182%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-142,319 USD 21%
Operating Lease, Liability $797,405 USD -33.45%
Lessee, Operating Lease, Liability, to be Paid $819,489 USD -34.49%
Operating Lease, Liability, Current $442,221 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $266,034 USD -40.21%
Lessee, Operating Lease, Liability, to be Paid, Year One $444,934 USD 2.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $22,084 USD -58.11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Additional Paid in Capital $154,650,064 USD 27%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $108,777 USD
Share-based Payment Arrangement, Expense $185,392 USD -73.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%